A business in context
BRKR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-15 | Munch Mark | M · Exercise / conversion | Common Stock | 2000.0 | 22.19 |
| 2026-09-15 | Munch Mark | S · Sale | Common Stock | 2000.0 | 52.87 |
| 2026-09-15 | Munch Mark | M · Exercise / conversion | Stock Option (Right to Purchase) | 2000.0 | 0.0 |
| 2026-08-17 | Pusch Wolfgang | S · Sale | Common Stock | 3473.0 | 56.9 |
| 2026-08-15 | Pusch Wolfgang | A · Grant / award | Common Stock | 3120.0 | 0.0 |
| 2026-08-15 | Pusch Wolfgang | A · Grant / award | Stock Option (Right to Purchase) | 2529.0 | 0.0 |
| 2026-08-15 | Bures Thomas | A · Grant / award | Common Stock | 4035.0 | 0.0 |
| 2026-08-15 | Srega Juergen | A · Grant / award | Common Stock | 16898.0 | 0.0 |
| 2026-08-15 | Srega Juergen | A · Grant / award | Stock Option (Right to Purchase) | 13698.0 | 0.0 |
| 2026-08-15 | Prause Burkhard | A · Grant / award | Common Stock | 3303.0 | 0.0 |
| 2026-08-15 | Prause Burkhard | A · Grant / award | Stock Option (Right to Purchase) | 2678.0 | 0.0 |
| 2026-08-15 | Munch Mark | A · Grant / award | Common Stock | 14443.0 | 0.0 |
| 2026-08-15 | Munch Mark | F · Tax / exercise payment | Common Stock | 2984.0 | 57.7 |
| 2026-08-15 | Munch Mark | A · Grant / award | Stock Option (Right to Purchase) | 11708.0 | 0.0 |
| 2026-08-15 | Herman Gerald N | A · Grant / award | Common Stock | 15794.0 | 0.0 |
| 2026-08-15 | Herman Gerald N | F · Tax / exercise payment | Common Stock | 2724.0 | 57.7 |
| 2026-08-15 | Herman Gerald N | A · Grant / award | Stock Option (Right to Purchase) | 12803.0 | 0.0 |
| 2026-08-15 | LAUKIEN FRANK H | F · Tax / exercise payment | Common Stock | 4760.0 | 57.7 |
| 2026-08-15 | LAUKIEN FRANK H | A · Grant / award | Common Stock | 29463.0 | 0.0 |
| 2026-08-15 | LAUKIEN FRANK H | A · Grant / award | Stock Option (Right to Purchase) | 71651.0 | 0.0 |
| 2026-08-14 | Munch Mark | S · Sale | Common Stock | 2000.0 | 57.6 |
| 2026-08-14 | Munch Mark | M · Exercise / conversion | Common Stock | 2000.0 | 22.19 |
| 2026-08-14 | Munch Mark | M · Exercise / conversion | Stock Option (Right to Purchase) | 2000.0 | 0.0 |
| 2026-08-11 | Munch Mark | F · Tax / exercise payment | Common Stock | 1619.0 | 57.02 |
| 2026-08-11 | Herman Gerald N | F · Tax / exercise payment | Common Stock | 1410.0 | 57.02 |
| 2026-08-11 | LAUKIEN FRANK H | F · Tax / exercise payment | Common Stock | 4838.0 | 57.02 |
| 2026-08-10 | Munch Mark | F · Tax / exercise payment | Common Stock | 1573.0 | 56.32 |
| 2026-08-10 | Herman Gerald N | F · Tax / exercise payment | Common Stock | 1289.0 | 56.32 |
| 2026-08-10 | LAUKIEN FRANK H | F · Tax / exercise payment | Common Stock | 4564.0 | 56.32 |
| 2026-08-09 | Munch Mark | F · Tax / exercise payment | Common Stock | 1904.0 | 53.41 |
| 2026-08-09 | Herman Gerald N | F · Tax / exercise payment | Common Stock | 1600.0 | 53.41 |
| 2026-08-09 | LAUKIEN FRANK H | F · Tax / exercise payment | Common Stock | 2361.0 | 53.41 |
| 2026-07-15 | Munch Mark | M · Exercise / conversion | Common Stock | 2000.0 | 22.19 |
| 2026-07-15 | Munch Mark | S · Sale | Common Stock | 2000.0 | 60.25 |
| 2026-07-15 | Munch Mark | M · Exercise / conversion | Stock Option (Right to Purchase) | 2000.0 | 0.0 |
Identity & relationships
SEC issuer · 0001109354BRUKER CORP
Search names and former names
- BRUKER BIOSCIENCES CORP · former SEC name · 2003-07-24 to 2008-02-27
- BRUKER DALTONICS INC · former SEC name · 2000-06-20 to 2003-07-02
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $3.37B | $3.62B |
| 2023-12-31 | $2.96B | $3.28B |
| 2022-12-31 | $2.53B | $2.91B |
| 2021-12-31 | $2.42B | $3.01B |
| 2020-12-31 | $1.99B | $2.59B |
| 2019-12-31 | $2.07B | $2.73B |
| 2018-12-31 | $1.90B | $2.54B |
| 2017-12-31 | $1.77B | $2.43B |